Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Frank Alexis studied in Montpellier (France) at the Technological University of Montpellier where he completed his B.Sc. in Chemistry and M.S. in Materials Science and Interfaces. His Ph.D. studies on drug eluting biodegradable stents were carried at the School of Material Sciences of Nanyang Technological University in Singapore. He completed a postdoctoral training at the Institute of Bioengineering and Nanotechnology in Singapore on gene delivery. After finishing his postdoctoral training in Singapore, he joined MIT and the Brigham and Women Hospital to work with Institute Professor Robert Langer and Dr Omid Farokhzad, respectively. As a postdoctoral fellow at the Brigham and Women’s Hospital in the laboratory of Dr. Omid Farokhzad and Research Affiliate at the Massachusetts Institute of Technology from 2006 to 2009 in the laboratory of Prof. Robert Langer, he developed multiple nanoparticle technologies including targeted nanoparticles for cancer therapy, oral drug delivery, and vaccines. In 2009, he joined the Bioengineering Department at Clemson University as an Assistant Professor. Dr. Alexis’ research interests are related to biomaterials, tissue engineering, and nanotechnology. He has ten intellectual properties in the field of drug delivery and nanotechnology licensed to industry. He is reviewer for more than 40 scientific journals.
Drug elutingbiodegradable stents
, Ocular Pharmacology and Therapeutics, Molecular Imaging,Gene Transfer
, Immunonanotherapeutics, Nanomedicine
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals